I Alexandre,O Rixe
I Alexandre
Hormone-refractory prostate cancer is an advanced stage of the metastatic disease; it has a poor prognosis and a short median survival, about 9 to 18 months. The current article is based on a literature review regarding the prognostic facto...
R O Fourcade
R O Fourcade
"Often done, better done" is a popular saying that may lead health authorities to use the volume of surgical activity to assess surgical quality, including eventually this criteria in their certification manual. Very few data indeed support...
P Coloby,P Zufferey
P Coloby
Two aspects are considered: the prevention of peri-operative venous thromboembolism, and the management of antiplatelet agents (APA) and anticoagulants during the peri-operative period. Thrombotic and haemorrhagic risk factors linked to the...
[Endoscope disinfection] [0.03%]
内镜的消毒
J P Mignard
J P Mignard
Economic considerations currently limit the idea of the disposable flexible endoscope, which would guarantee absolute safety against the transmission of infections. Since the endoscope is made of a heat-sensitive material, it is impossible ...
Jean-Luc Descotes,Jean-Dominique Doublet
Jean-Luc Descotes
Incidental diagnosis of renal tumors is more and more common. Imaging is of paramount importance for the caracterization of these tumors. Ultrasound allows the diagnosis of solid tumors, thereby excluding cysts. The gold standard is the CT-...
B Escudier
B Escudier
The treatment of metastatic renal cell carcinoma is deeply evolving. After the cytokines, interleukin 2 and interferon era, which raised great expectations followed by deep disillusions (related to an efficacy limited to a small group of pa...
C Coulange,J Hardwigsen,P Le Treut
C Coulange
Radical nephrectomy with vena cava thrombectomy remains the treatment of choice in patients with renal cell carcinoma and inferior vena cava involvement. Surgery is performed with curative intent in patients without evidence of metastases o...
[Renal cancer: what can we expect from emerging new technologies: radiofrequency and cryoablation?] [0.03%]
肾癌：新兴技术的前景：射频与冷冻消融？
P Liberati,O Mathieu,E Tariel et al.
P Liberati et al.
Radiofrequency and cryoablation are both minimally invasive techniques applied to the treatment of renal cell carcinoma. These techniques allow in situ destruction of neoplasm. Although cryotherapy is the most studied, radiofrequency is the...
[How far should partial nephrectomy be extended for renal cell carcinoma?] [0.03%]
肾细胞癌的肾部分切除术应多切些吗？
A Méjean
A Méjean
Conservative renal surgery for cancer has now achieved consensus for imperative, relative, and elective indications (tumor < 4 cm with healthy contralateral kidney). The results show 90%-100% 10-year survival rates and 0%-3% recurrence rate...
[Antithrombotic drugs in urological surgery. Treatment interfering with haemostasis in urology?] [0.03%]
抗凝血药物在泌尿外科手术中的应用: 泌尿科的止血治疗问题？
Paul Zufferey
Paul Zufferey
In storing or withholding a treatment that interferes haemostasis should be considered after assessing the benefit-risk ratio which requires the understanding of the efficacy, safety and pharmacology of heamostatic agents. This benefit to r...